Bill is Senior Vice President of Pfizer Vaccine Clinical Research and Development, and responsible for global clinical research and development of vaccines to meet licensure and post licensure requirements. He has over 35 years of experience in vaccine development. Bill joined in 1999 as Vice President of Clinical Vaccine Research and Development for Wyeth, now Pfizer Inc. Other experience includes: Associate Professor of Pediatrics in the Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine, Director of the Diagnostic Virology Laboratory at Vanderbilt University Hospital.

Dr. Gruber’s clinical research group has been responsible for global clinical research and development of now licensed pneumococcal conjugate, meningococcal conjugate, rLP2086 meningococcal B, influenza and SARS-CoV-2 (COVID-19) vaccines, as well as investigational Staph aureus, C. difficile, HIV, RSV, parainfluenza, HSV vaccines, pentavalent meningococcal vaccine, and mRNA vaccines against influenza and varicella-zoster. Dr. Gruber also guides the clinical research and development for Pfizer’s Group B streptococcus and RSV maternal immunization vaccine programs, as well as vaccines against Lyme disease and next generation COVID-19 vaccines.

He is Board certified in Pediatrics and Pediatric Infectious Diseases, Fellow of the American Academy of Pediatrics, Fellow of the Infectious Diseases Society of America, Fellow of the Pediatric Infectious Diseases Society, member of the Society for Pediatric Research, and member of the America Society for Microbiology.

Consultant/reviewer: NIAID, PATH, Bill and Melinda Gates Foundation, and scientific journals.

Education: BA, Mathematical Sciences, Rice University, Houston, Texas; MD, Baylor College of Medicine, Houston, Texas; Pediatric Residency, Chief Residency, and Pediatric Infectious Disease Fellowship, Baylor College of Medicine, and Texas Children’s Hospital, Houston, Texas.

Authorship/co-authorship on more than 200 original research articles, invited articles, and book chapters.

SVP Vaccine Clinical Research and Development, Pfizer Inc

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in the industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Dr. Mary Anne Marovich joined NIAID’s Division of AIDS as the Director of the Vaccine Research Program in 2012 to lead the development, strategic planning and coordination of global clinical testing and preclinical research on HIV vaccines and biologics. The Program has built an increasingly diverse and complex portfolio of vaccine candidates, monoclonal antibodies, and adjuvants for early-stage clinical testing through large scale international efficacy trials to find effective and acceptable protection from HIV infection. More recently, Marovich supported the federal COVID response (formerly Operation Warp Speed) as co-chair of the clinical vaccine development team and lead on anti-viral monoclonal antibodies for prevention.

Marovich comes to NIH from the Walter Reed Army Institute of Research (WRAIR)/Military HIV Research Program, where she served as chief of vaccine research and development since 2005. In that position, she led, directed, and developed a global HIV vaccine research program. Additionally, Marovich directed the Dendritic Cell Laboratory and the MHRP’s Rockville Vaccine Assessment Center and led multiple early-stage HIV and non-HIV vaccine clinical trials. She also served as chair of the WRAIR Institutional Review Board.

Marovich earned bachelor’s degrees in biochemistry and chemistry at Illinois State University and a medical degree at Loyola University of Chicago. In 1993, she completed her internal medicine residency, then became chief medical resident, followed by clinical infectious disease training at the University of Colorado. During residency, Marovich earned a diploma in tropical medicine and hygiene from the Royal College of Physicians and Surgeons, London School of Tropical Medicine and Hygiene. Marovich worked in NIAID’s Laboratory of Parasitic Diseases as a clinical fellow studying immunology from 1995-1998 and as a clinical associate from 1998-99 while she completed her infectious disease fellowship.

A professor of medicine with the Uniformed Services University’s Department of Medicine, Marovich has won several honors for academic research and teaching excellence. She is a member of the American Medical Association, Infectious Disease Society of America, American Society of Tropical Medicine, and a Fellow of the American College of Physicians.

National Institutes of Health, National Institute of Allergy and Infectious Diseases,
Division of AIDS, Director, Vaccine Research Program